Delivery Order SPE2DB20D1100-SPE2DB25FB9S6

Award Date 4/28/25
Potential Completion Date 4/29/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $3,638.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Lyrica 25 mg capsules, a prescription medication, with a period of performance through May 1, 2025. The contract is a firm-fixed-price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,445.82 firm-fixed-price delivery order is for the supply of Lyrica 75 mg capsules, a medication used to treat certain types of nerve pain. The contract has a completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FA0N1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,933.41, is for the delivery of Lyrica 50 mg capsules. It is a firm fixed-price delivery order contract with a completion date of January 15, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $13,961.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,567,117,597 units of the pharmaceutical product Lyrica 50 mg Capsules, with a completion date of February 3, 2025. The contract has a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,281.97 firm fixed-price delivery order contract covers the supply of LYRICA 100 mg capsules, a prescription medication primarily used to treat neuropathic pain. The contract has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,182.30, is a delivery order for the provision of Lyrica 75 mg capsules. The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price arrangement. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award, valued at $8,867.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a prescription medication used to treat certain types of nerve pain. The contract has an ultimate completion date of December 14, 2023 and is structured as a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract....
This federal contract award, valued at $1,044.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lyrica 50 mg capsules, a medication used to treat various conditions including neuropathic pain, seizures, and fibromyalgia. The contract has a firm fixed price and is a delivery order with a completion date of December 22, 2023. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,914.46, is a Firm Fixed Price Delivery Order for the supply of Lyrica 50 mg capsules. The contract has an ultimate completion date of March 12, 2025 and was awarded on March 11, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $11,508.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Lyrica 50 mg capsules to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB9S6
    Delivery Order

This federal contract award, valued at $3,650.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order (SPE2DB20D1100|SPE2DB25FB9S6) for the supply of Lyrica 50 mg capsules, a medication used to treat nerve pain. The contract has a firm fixed-price pricing type and an ultimate completion date of April 29, 2025.

AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00 (SPE2DX), which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 7/28/25, 11:12 AM